SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

drug approval expired 75% Health

SynbioTech has launched SYNMUE™, a clinically validated probiotic targeting immune aging, demonstrated to increase natural killer cell levels by up to 48%. The product will be showcased at the Probiota Americas 2026 event in Vancouver.

🇨🇦 Location: Vancouver — Sources: 1 — First seen: — Last seen:
SynbioTech SYNMUE probiotic immunosenescence natural killer cells

Contributing Articles